GC-MS Chemical Profiling, Biological Investigation of Three Salvia Species Growing in Uzbekistan

• Published in: Molecules (Basel, Switzerland) Switzerland), 2022-08, Vol.27 (17), p.5365
• Main Authors: Gad, Haidy A., Mamadalieva, Rano Z., Khalil, Noha, Zengin, Gokhan, Najar, Basma, Khojimatov, Olim K., Al Musayeib, Nawal M., Ashour, Mohamed L., Mamadalieva, Nilufar Z.
• Format: Article
• Language: English
• Subjects: Acetylcholinesterase; Acids; Alzheimer's disease; Amylases; Antioxidants; Assaying; Chelation; chemical profile; chemometric analysis; Diabetes; enzyme inhibition; Enzymes; Essential oils; Galantamine; GC-MS; Glucosidase; Hyperpigmentation; Iron constituents; Kojic acid; Least squares method; Natural products; Oils & fats; Principal components analysis; Regression analysis; Salvia; Salvia sclarea; Sulfonic acid; Thujone; Tyrosinase; Vitamin E; α-Amylase; α-Glucosidase
• ISSN: 1420-3049; 1420-3049
• DOI: 10.3390/molecules27175365

Salvia is a potentially valuable aromatic herb that has been used since ancient times. The present work studied the chemical profile of three Salvia species essential oils (EO): S. officinalis, S. virgata and S. sclarea, as well as assessing their antioxidant and enzyme inhibitory activities. A total of 144 compounds were detected by GC-MS analysis, representing 91.1, 84.7 and 78.1% in S. officinalis, S. virgata and S. sclarea EOs, respectively. The major constituents were cis-thujone, 2,4-hexadienal and 9-octadecenoic acid, respectively. The principal component analysis (PCA) score plot revealed significant discrimination between the three species. The antioxidant activity of the EOs was evaluated using in vitro assays. Only S. virgata EO showed antioxidant activity in the 2,2-diphenyl-1-picryl-hydrazyl (DPPH) assay (26.6 ± 1.60 mg Trolox equivalent (TE)/g oil). Moreover, this oil exhibited the highest antioxidant activity in 2,2-azino bis (3-ethylbenzothiazoline-6-sulphonic acid) (ABTS), cupric-reducing antioxidant capacity (CUPRAC) and ferric-reducing power (FRAP) assays in comparison with the other two EOs (190.1 ± 2.04 vs. 275.2 ± 8.50 and 155.9 ± 1.33 mg TE/g oil, respectively). However, S. virgata oil did not show any effect in the chelating ability assay, while in the PBD assay, S. officinalis had the best antioxidant activity (26.4 ± 0.16 mmol TE/g oil). Enzyme inhibitory effect of the EOs was assessed against acetylcholinesterase (AChE) and butyrylcholinesterase (BChE), tyrosinase, α-glucosidase and α-amylase. AChE enzyme was more sensitive to S. officinalis EO (4.2 ± 0.01 mg galantamine equivalent (GALAE)/g oil), rather than S. virgata EO, which was ineffective. However, S. virgata had the highest BChE effect (12.1 ± 0.16 mg GALAE/g oil). All studied oils showed good tyrosinase inhibitory activity, ranging between 66.1 ± 0.61 and 128.4 ± 4.35 mg kojic acid equivalent (KAE)/g oil). Moreover, the EOs did not exhibit any glucosidase inhibition and were weak or inefficient on amylase enzyme. Partial least squares regression (PLS-R) models showed that there is an excellent correlation between the antioxidant activity and the volatile profile when being compared to that of enzyme inhibitory activity. Thus, the studied Salvia essential oils are interesting candidates that could be used in drug discovery for the management of Alzheimer’s and hyperpigmentation conditions.